×

Biomarkers

B7-H3 stands out as future SCLC target

B7-H3 stands out as future SCLC target

B7-H3 stands out as future SCLC targetBY CHRISTINE KILGORE MDedge News FROM THE JOURNAL FOR IMMUNOTHERAPY OF CANCER About two out of three patients with small cell lung cancer (SCLC) express B7-H3, a B7 family ligand that may one day serve as a therapeutic target,...

read more

Continue Reading


Biomarkers


+

Prevention


+

Cost And Coping


+

Diagnosis and Therapy


+

Patient Journey


+